Experts Guide
UAB’s public relations specialists are the fastest, most efficient way for reporters to reach UAB experts on deadline. Call 205-934-3884.

We also have a full-service broadcast team that can facilitate interviews for TV, radio or Skype and provide b-roll or sound on request. Search by topic or name to find featured experts or contact Public Relations for additional information.
Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu • (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and toxicology; Alabama Drug Discovery Alliance; Harbert Institute for Innovation and Entrepreneurship.

These results, seen in animal models, represent a potentially novel therapeutic target for the treatment of seizure disorders.
This structure will further explain how the virus infects human cells and how progeny viruses are assembled, and it may be a point of attack to disarm the virus.
Low dietary potassium leads to calcified arteries and aortic stiffness, while increased dietary potassium alleviates those undesirable effects in a mouse model, suggesting dietary potassium may protect against heart disease and death from heart disease in humans.
Researchers study the mechanisms that prevent autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis after an infection.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.

A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.

These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
Page 7 of 21
Back to Top